
Eli Lilly Stock Jumps, Reversing Early Losses, After Weight-Loss Behemoth Misses
Eli Lilly (LLY) stock reversed higher Thursday on its upbeat outlook despite lighter-than-expected fourth-quarter sales of its well-known weight-loss and diabetes drugs. ↑ X NOW PLAYING The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy? During the fourth quarter, obesity treatment Zepbound brought in $1.91 billion in sales, while…